Tân Chủ tịch Quốc hội Iran: Đàm phán, thỏa hiệp với Mỹ là “vô ích”

Ngày 31/5, truyền thông Trung Đông dẫn tuyên bố của Chủ tịch Quốc hội Iran Mohammad-Bagher Ghalibaf cho rằng bất kỳ cuộc đàm phán nào với Mỹ cũng sẽ là “vô ích.”

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh